0001104659-15-049016.txt : 20150630 0001104659-15-049016.hdr.sgml : 20150630 20150630184634 ACCESSION NUMBER: 0001104659-15-049016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SV Life Sciences Fund V Strategic Partners, L.P. CENTRAL INDEX KEY: 0001482194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 15962720 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-973-2708 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SV LIFE SCIENCES FUND V LP CENTRAL INDEX KEY: 0001460732 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 15962721 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-973-2708 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SV Life Sciences Fund V (GP), LP CENTRAL INDEX KEY: 0001644146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 15962722 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SVLSF V, LLC CENTRAL INDEX KEY: 0001644160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 15962723 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 4 1 a4.xml 4 X0306 4 2015-06-30 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001644160 SVLSF V, LLC ONE BOSTON PLACE 201 WASHINGTON STREET SUITE 3900 BOSTON MA 02108 0 0 1 0 0001644146 SV Life Sciences Fund V (GP), LP ONE BOSTON PLACE 201 WASHINGTON STREET SUITE 3900 BOSTON MA 02108 0 0 1 0 0001460732 SV LIFE SCIENCES FUND V LP ONE BOSTON PLACE 201 WASHINGTON STREET SUITE 3900 BOSTON MA 02108 0 0 1 0 0001482194 SV Life Sciences Fund V Strategic Partners, L.P. ONE BOSTON PLACE 201 WASHINGTON STREET SUITE 3900 BOSTON MA 02108 0 0 1 0 Common Stock 2015-06-30 4 C 0 1651223 A 1651223 I See Footnotes Common Stock 2015-06-30 4 C 0 34893 A 34893 I See Footnotes Common Stock 2015-06-30 4 C 0 764309 A 2415532 I See Footnotes Common Stock 2015-06-30 4 C 0 16152 A 51045 I See Footnotes Common Stock 2015-06-30 4 P 0 382996 12 A 2798528 I See Footnotes Common Stock 2015-06-30 4 P 0 8094 12 A 59139 I See Footnotes Series A Preferred Stock 2015-06-30 4 C 0 21218253 0 D Common Stock 1651223 0 I See Footnotes Series A Preferred Stock 2015-06-30 4 C 0 448414 0 D Common Stock 34893 0 I See Footnotes Series B Preferred Stock 2015-06-30 4 C 0 9821385 0 D Common Stock 764309 0 I See Footnotes Series B Preferred Stock 2015-06-30 4 C 0 207558 0 D Common Stock 16152 0 I See Footnotes The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. These shares are owned directly by SV Life Sciences Fund V, L.P. ("SVLS V LP"). SV Life Sciences Fund V (GP), LP ("SVLS V GP") is the general partner of SVLS V LP. The general partner of SVLS V GP is SVLSF V, LLC. The members of the investment committee of SVLSF V, LLC are Kate Bingham, James Garvey, Eugene D. Hill, III, David Milne and Michael Ross. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V LP and SVLS V SPP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaim beneficial ownership of the shares owned directly by SVLS V LP except to the extent of any pecuniary interest therein. These shares are owned directly by SV Life Sciences Fund V Strategic Partners, L.P. ("SVLS V SPP"). SV Life Sciences Fund V (GP), LP ("SVLS V GP") is the general partner of SVLS V SPP. The general partner of SVLS V GP is SVLSF V, LLC. The members of the investment committee of SVLSF V, LLC are Kate Bingham, James Garvey, Eugene D. Hill, III, David Milne and Michael Ross. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V LP and SVLS V SPP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaim beneficial ownership of the shares owned directly by SVLS V SPP except to the extent of any pecuniary interest therein. SVLS V LP and SVLS V SPP (each a "Fund," or collectively the "Funds") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein. By:/s/ Denise Marks, Member of SVLSF V, LLC 2015-06-30 By:/s/ Denise Marks, Member of SVLSF V, LLC, general partner of SV Life Sciences Fund V (GP), L.P. 2015-06-30 By:/s/ Denise Marks, Member of SVLSF V, LLC, general partner of SV Life Sciences Fund V (GP), L.P., general partner of SV Life Sciences Fund V, L.P. 2015-06-30 By:/s/ Denise Marks, Member of SVLSF V, LLC, general partner of SV Life Sciences Fund V (GP), L.P., general partner of SV Life Sciences Fund V Strategic Partners, L.P. 2015-06-30